M. Klag

发表

Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension.

P. Whelton, L. Appel, Jiang He, 2000, Hypertension.

Depression is a risk factor for coronary artery disease in men: the precursors study.

D. Ford, L. Cooper-Patrick, M. Klag, 1998, Archives of internal medicine.

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Ethan M Balk, Nathan W. Levin, Susan L. Furth, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study.

N. Powe, J. Coresh, A. Levey, 2002, Journal of the American Society of Nephrology : JASN.

Seven-year incidence of hypertension in a cohort of middle-aged African Americans and whites.

P. Whelton, L. Appel, Jiang He, 1998, Hypertension.

Short- and long-term prognosis after acute myocardial infarction in Chinese men and women.

P. Whelton, J. He, M. Klag, 1994, American journal of epidemiology.

Frequency of sit-down patient care rounds, attainment of clinical performance targets, hospitalization, and mortality in hemodialysis patients.

Josef Coresh, N. Powe, J. Coresh, 2004, Journal of the American Society of Nephrology : JASN.

Frequency of patient-physician contact and patient outcomes in hemodialysis care.

N. Powe, H. Rubin, J. Coresh, 2004, Journal of the American Society of Nephrology : JASN.

MYH9 is associated with nondiabetic end-stage renal disease in African Americans

D. Reich, N. Patterson, N. Powe, 2008, Nature Genetics.

Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease.

M. Pfeffer, B. Kasiske, G. Eknoyan, 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The Effects of Nonpharmacologic Interventions on Blood Pressure of Persons With High Normal Levels: Results of the Trials of Hypertension Prevention, Phase I

N. Cook, J. Buring, P. Whelton, 1992 .

Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs.

T V Perneger, P. Whelton, T. Perneger, 1994, The New England journal of medicine.

The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials.

P. Whelton, S. Jee, J. He, 1999, Hypertension.

The decline in stroke mortality. An epidemiologic perspective.

P. Whelton, M. Klag, 1993, Annals of epidemiology.

Premature deaths attributable to blood pressure in China: a prospective cohort study

K. Reynolds, P. Whelton, Ji-chun Chen, 2009, The Lancet.

Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: a prospective cohort study

N. Powe, J. Coresh, M. Klag, 2007, BMC Health Services Research.

Comorbidity and its change predict survival in incident dialysis patients.

N. Powe, J. Coresh, A. Levey, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Familial aggregation of renal disease in a population-based case-control study.

P. Whelton, J. Coresh, T. Perneger, 1998, Journal of the American Society of Nephrology : JASN.

Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy.

P. Kimmel, J. Coresh, R. Rasooly, 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Epidemiology and prevention of blood pressure-related renal disease.

P. Whelton, T. Perneger, F. Brancati, 1992, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Feasibility of using recipients of health promotional newsletters for post-marketing surveillance.

D. Ford, M. Klag, L. Mead, 2000, Journal of clinical epidemiology.

Medical specialty and the incidence of divorce.

B. Rollman, M. Klag, L. Mead, 1997, The New England journal of medicine.

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Keith C. Norris, A. Gotto, G. Eknoyan, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study.

N. Powe, J. Coresh, M. Klag, 2006, Kidney international.

Stroke in the People's Republic of China. I. Geographic variations in incidence and risk factors.

Zheng-lai Wu, P. Whelton, J. He, 1995, Stroke.

Risk of stroke in male cigarette smokers.

P. Whelton, M. Klag, 1987, The New England journal of medicine.

The classics: a tribute to the fiftieth anniversary of the randomized clinical trial.

P. Whelton, F. Fuchs, M. Klag, 2000, Journal of clinical epidemiology.

Frequency of patient-physician contact in chronic kidney disease care and achievement of clinical performance targets.

N. Powe, J. Coresh, M. Klag, 2005, International journal for quality in health care : journal of the International Society for Quality in Health Care.

Alcohol use and retinal vessels: insights into the mechanism of alcohol-induced stroke.

M. Klag, R. Moore, G. Comstock, 1989, International journal of epidemiology.

Community cholesterol screening. Impact of labeling on participant behavior.

P. Whelton, M. Klag, R. Gordon, 1990, Archives of internal medicine.

The renin-angiotensin system and blood pressure: differences between blacks and whites.

P. Whelton, L. Appel, J. He, 1999, American journal of hypertension.

Effect of migration and related environmental changes on serum lipid levels in southwestern Chinese men.

Zheng-lai Wu, P. Whelton, J. He, 1996, American journal of epidemiology.

Magnesium and blood pressure: review of the epidemiologic and clinical trial experience.

P. Whelton, M. Klag, P. K. Whelton, 1989, The American journal of cardiology.

The association of sudden cardiac death with inflammation and other traditional risk factors.

N. Powe, J. Coresh, M. Klag, 2008, Kidney international.

Body mass and blood pressure in a lean population in southwestern China.

P. Whelton, M. Klag, M. Klag, 1994, American journal of epidemiology.

The role of blood pressure as a risk factor for renal disease: a review of the epidemiologic evidence.

P. Whelton, T. Perneger, M. Klag, 1996, Journal of human hypertension.

Body Mass Index and Risk of Incident Hypertension Over the Life Course

Audrey Y. Chu, K. Liang, D. Ford, 2012 .

Alcohol: role in the development of hypertension and end-stage renal disease

M. Klag, R. Parekh, M. Klag, 2001, Current opinion in nephrology and hypertension.

Prediction of Steroid Responsiveness in the Idiopathic Nephrotic Syndrome Using Urinary Retinol-binding Protein and Beta-2-Microglobulin

M. Klag, M. Klag, A. B. Pereira, 1992, Annals of Internal Medicine.

Low birth weight is associated with chronic kidney disease only in men.

G. Bakris, K. Norris, M. Shlipak, 2008, Kidney international.

Cause of death in patients with end-stage renal disease: death certificates vs registry reports.

P. Whelton, T. Perneger, M. Klag, 1993, American journal of public health.

End-Stage Renal Disease Attributable to Diabetes Mellitus

P. Whelton, T. Perneger, F. Brancati, 1994, Annals of Internal Medicine.

End-stage Renal Disease in African-American and White Men

P. Whelton, J. Neaton, J. Stamler, 2016 .

Effectiveness of the Waksberg telephone sampling method for the selection of population controls.

P. Whelton, T. Perneger, M. Klag, 1993, American journal of epidemiology.

Diagnosis of hypertensive end-stage renal disease: effect of patient's race.

P. Whelton, T. Perneger, M. Klag, 1995, American journal of epidemiology.

High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.

N. Powe, J. Coresh, A. Levey, 2005, Journal of the American Society of Nephrology : JASN.

Small Apolipoprotein(a) Size Predicts Mortality in End-Stage Renal Disease: The CHOICE Study

N. Powe, J. Coresh, M. Klag, 2002, Circulation.

Positive attitude. The first step to living long and well with kidney disease.

Cnn, P. Kimmel, K. Johansen, 2002, Nephrology news & issues.

Projections of hypertension-related renal disease in middle-aged residents of the United States.

T V Perneger, P. Whelton, T. Perneger, 1993, JAMA.

Blood pressure and end-stage renal disease in men.

P. Whelton, J. Neaton, J. Stamler, 1996, The New England journal of medicine.

End-stage renal disease in African-American and white men. 16-year MRFIT findings.

P. Whelton, J. Neaton, J. Stamler, 1997, JAMA.

Incidence and risk factors for gout in white men.

K. Liang, M. Hochberg, M. Klag, 1991, JAMA.

The contribution of urinary cations to the blood pressure differences associated with migration.

P. Whelton, J. Coresh, M. Klag, 1995, American journal of epidemiology.

Epidemiology of high blood pressure.

P. Whelton, M. Klag, 1989, Clinics in geriatric medicine.

Epidemiological Considerations in the Treatment of Hypertension

P. Whelton, M. Klag, 2012, Drugs.

Coffee and Risk of Subclinical Myocardial Damage and Cardiovascular Events b . Abbreviated Title ( Length 26 characters ) : Coffee and hs-cTnT 2

J. McEvoy, R. Blumenthal, C. Ballantyne, 2016 .

Migration, blood pressure pattern, and hypertension: the Yi Migrant Study.

P. Whelton, M. Klag, M. Klag, 1991, American journal of epidemiology.

Vitamin C status and mortality in US adults.

P. Whelton, C. Loria, L. Caulfield, 2000, The American journal of clinical nutrition.

Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition.

N. Powe, J. Coresh, M. Klag, 2004, JAMA.

Epidemiology of cardiovascular risk factors in chronic renal disease.

J. Coresh, M. Klag, E. Miller, 1998, Journal of the American Society of Nephrology : JASN.

Stroke in the People's Republic of China. II. Meta-analysis of hypertension and risk of stroke.

Zheng-lai Wu, P. Whelton, M. Klag, 1995, Stroke.

Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994).

J. Coresh, A. Levey, F. Brancati, 2001, Archives of internal medicine.

Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition.

N. Powe, J. Coresh, M. Klag, 2004, JAMA.

Racial differences in the incidence of gout. The role of hypertension.

M. Hochberg, D. Levine, M. Klag, 1995, Arthritis and rheumatism.

Gout and risk for subsequent coronary heart disease. The Meharry-Hopkins Study.

M. Hochberg, M. Klag, A. Gelber, 1997, Archives of internal medicine.

Blood Pressure and Skin Color-Reply

P. Whelton, J. Coresh, L. Kuller, 1991 .

Alcohol consumption and blood pressure: a comparison of native Japanese to American men.

P. Whelton, M. Klag, M. Klag, 1990, Journal of clinical epidemiology.

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Bertram L Kasiske, Marc Pfeffer, Josef Coresh, 2003, Hypertension.

Agreement among indicators of vitamin C status.

P. Whelton, M. Szklo, C. Loria, 1998, American journal of epidemiology.

Lipoprotein(a) level as a predictor of cardiovascular disease and small apoliprotein(a) isoforms in dialysis patients: assay-related differences are important.

N. Powe, J. Coresh, M. Klag, 2008, Clinica chimica acta; international journal of clinical chemistry.

Undertreatment of hyperlipidemia in a cohort of United States kidney dialysis patients.

N. Powe, J. Coresh, C. Fox, 2004, Clinical nephrology.

Literature abstract

M. Klag, R. Sesso, J. T. Carvalhaes, 2004, Pediatric Nephrology.

Bertram L Kasiske, Marc Pfeffer, Josef Coresh, 2003, Circulation.

Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials.

P. Whelton, Jiang He, M. Klag, 1998, JAMA.

Relationship of Treatment for Hypertension and Stroke Mortality

S. Kameyama, M. Klag, 2022 .

Plasma insulin levels and incidence of hypertension in African Americans and whites.

P. Whelton, L. Appel, B. Caballero, 1999, Archives of internal medicine.

Agreement between overnight and 24-hour urinary cation excretions in southern Chinese men.

P. Whelton, J. Coresh, M. Klag, 1993, American journal of epidemiology.

Factors associated with high density lipoprotein cholesterol in Japanese and American telephone executives.

P. Whelton, M. Klag, K. Ohara, 1991, American journal of epidemiology.

The accuracy and precision of the Accutracker ambulatory blood pressure monitor.

P. Whelton, L. Appel, M. Klag, 1990, American journal of epidemiology.

Genome-Wide Scan for Estimated GFR in Multi-Ethnic Diabetic Populations: The Family Investigation of Nephropathy and Diabetes of Nephropathy

R. Elston, P. Kimmel, K. Taylor, 2007 .

Summary and Comment: Frequency of Sit‐Down Patient Care Rounds, Attainment of Clinical Performance Targets, Hospitalization, and Mortality in Hemodialysis Patients

N. Powe, J. Coresh, A. Levey, 2005 .

Kidney Transplantation from Living Unrelated Donors

P. Whelton, M. Klag, M. Klag, 1992, Annals of Internal Medicine.

Hypertension in African Americans.

M. Klag, 1996, Annals of epidemiology.

Race-specific association of lipoprotein(a) with vascular access interventions in hemodialysis patients: the CHOICE Study.

N. Powe, B. Astor, J. Coresh, 2002, Kidney international.

Timing of nephrologist referral and arteriovenous access use: the CHOICE Study.

N. Powe, B. Astor, J. Coresh, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD.

N. Powe, J. Coresh, A. Levey, 2000, Journal of the American Society of Nephrology : JASN.

Baseline characteristics of participants in phase I of the Trials of Hypertension Prevention.

P. Whelton, J. Cutler, N. Borhani, 1992, Annals of epidemiology.

The association of skin color with blood pressure in US blacks with low socioeconomic status.

P. Whelton, J. Coresh, L. Kuller, 1991, JAMA.

Lack of familial clustering of hepatitis C virus infection.

M. Klag, H. Lee, Y. Ahn, 1998, International journal of epidemiology.

"U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc.

A. Levey, M. Klag, J. Sadler, 1998, Kidney international.

Oats and buckwheat intakes and cardiovascular disease risk factors in an ethnic minority of China.

P. Whelton, M. Klag, J. Chen, 1995, The American journal of clinical nutrition.

Diabetes mellitus, race, and socioeconomic status. A population-based study.

P. Whelton, L. Kuller, L. Kuller, 1996, Annals of epidemiology.

Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study.

J. Coresh, M. Klag, P. Muntner, 2000, Kidney international.

A genome-wide admixture scan identifies MYH 9 as a candidate locus associated with non-diabetic end stage renal disease in African Americans

Jeffrey, Winkler, D. Reich, 2009 .

Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND)

Benjamin J. Keller, C. Rotimi, R. Elston, 2015, PLoS genetics.

Variation in utilization of procedures for treatment of peripheral arterial disease. A look at patient characteristics.

E. Bass, M. Klag, S. Tunis, 1993, Archives of internal medicine.

Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials.

P. Whelton, J. Cutler, L. Appel, 1997, JAMA.

Early predictors of career achievement in academic medicine.

D. Levine, F. Brancati, M. Klag, 1992, JAMA.

Relation between gender and vascular access complications in hemodialysis patients.

N. Powe, B. Astor, J. Coresh, 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease

Bruce Kupelnick, Nathan W. Levin, Roger Greenwood, 2004 .

Hypertension awareness, treatment, and control in chronic kidney disease.

G. Bakris, A. Collins, Suying Li, 2008, The American journal of medicine.

Lack of blood pressure effect with calcium and magnesium supplementation in adults with high-normal blood pressure. Results from Phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group.

N. Borhani, F. Sacks, C. Hennekens, 1995, Annals of epidemiology.

Haplotype of signal transducer and activator of transcription 3 gene predicts cardiovascular disease in dialysis patients.

N. Powe, J. Coresh, M. Klag, 2006, Journal of the American Society of Nephrology : JASN.

Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans

Nicholette D. Palmer, Jacob M. Keaton, M. Fornage, 2019, Human Genomics.

Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials.

P. Whelton, L. Appel, S. Jee, 2001, American journal of epidemiology.

Selecting SNPs informative for African, American Indian and European Ancestry: application to the Family Investigation of Nephropathy and Diabetes (FIND)

R. Elston, P. Kimmel, C. Winkler, 2016, BMC Genomics.

Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study.

Josef Coresh, Brad C Astor, N. Powe, 2005, Journal of the American Society of Nephrology : JASN.

Epidemiologic analysis of existing data to investigate hypertensive renal disease: an example from the Maryland End-Stage Renal Disease Registry.

P. Whelton, F. Brancati, M. Klag, 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort.

J. Coresh, Yongmei Liu, M. Fallin, 2006, Journal of the American Society of Nephrology : JASN.

High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention From the American Heart Association Councils on Kidney in Cardiovascular Disease, Kidney Disease as a Risk Factor for Development of Cardiovascular Disease : A Statement

M. Pfeffer, B. Kasiske, J. Coresh, 2013 .

Epidemiology and Prevention Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Statement From the American Heart Association Councils on Kidney in Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A

M. Pfeffer, B. Kasiske, P. Wilson, 2011 .

Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP).

M. Klag, W. Keane, W. Brown, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Three single-nucleotide polymorphisms in LPA account for most of the increase in lipoprotein(a) level elevation in African Americans compared with European Americans

J. Coresh, W. Kao, M. Klag, 2006, Journal of Medical Genetics.

Comparing the Risk for Death with Peritoneal Dialysis and Hemodialysis in a National Cohort of Patients with Chronic Kidney Disease

Josef Coresh, Nathan W Levin, N. Powe, 2005, Annals of Internal Medicine.

HDL Cholesterol and Mortality in Finnish Men With Special Reference to Alcohol Intake

D. Albanes, J. Virtamo, M. Klag, 1994, Circulation.

Exercise and depression in midlife: a prospective study.

D. Ford, L. Cooper-Patrick, M. Klag, 1997, American journal of public health.

End-stage renal disease in US minority groups.

P. Whelton, H. Feldman, M. Klag, 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Body weight patterns from 20 to 49 years of age and subsequent risk for diabetes mellitus: the Johns Hopkins Precursors Study.

K. Liang, F. Brancati, M. Klag, 1999, Archives of internal medicine.

Validity of physicians' self-reports of cardiovascular disease risk factors.

D. Ford, D. Levine, M. Klag, 1993, Annals of epidemiology.

Serum cholesterol in young men and subsequent cardiovascular disease.

K Y Liang, P. Whelton, K. Liang, 1993, The New England journal of medicine.

Patient characteristics related to intensity of weight reduction care in a university medical clinic

P. Whelton, L. Appel, D. Ford, 1992, Journal of General Internal Medicine.

Race and sex differences in the distribution of cerebral atherosclerosis.

B. Litt, J. Coresh, R. Wityk, 1996, Stroke.

Person-Years and Their Proportions of Coronary Risk Factor and HDL Cholesterol Categories in Two Age Groups of the Placebo Group of the ATBC Study Risk Factor Alcohol consumption Nondrinkers

D. Albanes, J. Virtamo, M. Klag, 2005 .

Effects of Oral Potassium on Blood Pressure: Meta-Analysis of Randomized Controlled Clinical Trials

P. Whelton, J. Cutler, L. Appel, 1998 .

Alcohol use and blood pressure in an unacculturated society.

P. Whelton, M. Klag, J. Chen, 1993, Hypertension.

Insomnia in young men and subsequent depression. The Johns Hopkins Precursors Study.

D. Ford, L. Cooper-Patrick, M. Klag, 1997, American journal of epidemiology.

Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP).

Keith C. Norris, J. McGill, G. Bakris, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A Prospective Study of Blood Pressure and Serum Creatinine: Results From the 'Clue' Study and the ARIC Study

P. Whelton, M. Szklo, T. Perneger, 1993 .

Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality.

N. Powe, J. Coresh, D. Ford, 2006, Clinical journal of the American Society of Nephrology : CJASN.

Risk of end-stage renal disease associated with alcohol consumption.

P. Whelton, T. Perneger, M. Klag, 1999, American journal of epidemiology.

Decline in US stroke mortality. Demographic trends and antihypertensive treatment.

P. Whelton, M. Klag, M. Klag, 1989, Stroke.

Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?

P. Whelton, M. Klag, J. Whittle, 1991, Archives of internal medicine.

Physician, heal Thyself? Regular source of care and use of preventive health services among physicians.

C. Gross, D. Ford, M. Klag, 2000, Archives of internal medicine.

Race and end-stage renal disease. Socioeconomic status and access to health care as mediating factors.

P. Whelton, T. Perneger, M. Klag, 1995, Archives of internal medicine.

The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors.

P. Whelton, F. Brancati, M. Klag, 1992, JAMA.

Risk of End-stage Renal Disease in Diabetes Mellitus: A Prospective Cohort Study of Men Screened for MRFIT

P. Whelton, J. Neaton, J. Stamler, 1997 .

Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial.

P. Whelton, J. Neaton, J. Stamler, 1997, JAMA.

Hypertension as a Risk Factor for Renal Disease Review of Clinical and Epidemiological Evidence

P. Whelton, M. Klag, 1989, Hypertension.

Reliability of urinary albumin, total protein, and creatinine assays after prolonged storage: the Family Investigation of Nephropathy and Diabetes.

P. Kimmel, W. Knowler, M. Klag, 2007, Clinical journal of the American Society of Nephrology : CJASN.

Plasma lipoprotein levels as predictors of cardiovascular death in women.

M. Klag, C. Newschaffer, T. Bush, 1993, Archives of internal medicine.

Are Low Levels of Carotenoids and a-Tocopherol Risk Factors for Myocardial Infarction?

M. Klag, R. Salkeld, G. Comstock, 2005 .

Prevention of Blood Pressure‐related Kidney Failure: An Epidemiological Perspective

P. Whelton, T. Perneger, M. Klag, 1993 .

Recreational drug use: a neglected risk factor for end-stage renal disease.

P. Whelton, T. Perneger, M. Klag, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Left ventricular hypertrophy and skin color among American blacks.

P. Whelton, J. Coresh, L. Kuller, 1991, American journal of epidemiology.

The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials.

Vikesh K. Singh, L. Appel, E. Guallar, 2002, American journal of hypertension.

Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP).

Keith C. Norris, J. McGill, G. Bakris, 2007, Archives of internal medicine.

History of hypertension in patients treated for end‐stage renal disease

P. Whelton, T. Perneger, M. Klag, 1997, Journal of hypertension.

Beta-fibrinogen haplotypes and the risk for cardiovascular disease in a dialysis cohort.

J. Coresh, Yongmei Liu, M. Fallin, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Body mass index in young men and the risk of subsequent knee and hip osteoarthritis.

M. Hochberg, M. Klag, A. Gelber, 1999, The American journal of medicine.

The coming epidemic: hypertension in rural Kyrgyzstan, Central Asia

M. Klag, J. H. Young, P. Parler, 2005, Journal of Human Hypertension.

Studying the causes of kidney disease in humans: a review of methodologic obstacles and possible solutions.

P. Whelton, T. Perneger, F. Brancati, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Effect of Age on the Efficacy of Blood Pressure Treatment Strategies

P. Whelton, L. Appel, M. Klag, 1990, Hypertension.

Choices for Healthy Outcomes In Caring for End Stage Renal Disease

N. Powe, A. Wu, H. Rubin, 1996 .

Youthful precursors of midlife social support.

J. Johnson, M. Klag, L. Mead, 1998, Journal of personality and social psychology.

Access to Care, Treatment Ambivalence, Medication Nonadherence, and Long‐Term Mortality Among Severely Hypertensive African Americans: A Prospective Cohort Study

D. Brotman, F. Brancati, M. Klag, 2015, Journal of clinical hypertension.

Vascular reactivity in young adults and cardiovascular disease. A prospective study.

P. Whelton, K. Liang, J. Coresh, 1992, Hypertension.

Predictors of transfusion for spinal surgery in Maryland, 1997 to 2000

P. Pronovost, S. Berenholtz, T. Dorman, 2002, Transfusion.

Association of Clinic Vascular Access Monitoring Practices with Clinical Outcomes in Hemodialysis Patients

N. Powe, B. Astor, M. Klag, 2006, Nephron Clinical Practice.

Exercise thallium scans: patterns of use and impact on management of patients with known or suspected coronary artery disease.

M. Klag, C. Boucher, H. Strauss, 1987, The American journal of cardiology.

Coffee intake and coronary heart disease.

A. LaCroix, K. Liang, J. Coresh, 1994, Annals of epidemiology.

Early, intermediate, and long-term risk factors for mortality in incident dialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study.

N. Powe, J. Coresh, A. Levey, 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Effect of age and gender on kidney function in renal transplant donors: a prospective study.

P. Whelton, M. Klag, R. Sesso, 1993, Clinical nephrology.

Functional variants in the lymphotoxin-alpha gene predict cardiovascular disease in dialysis patients.

J. Coresh, W. Kao, M. Klag, 2006, Journal of the American Society of Nephrology : JASN.

Physician knowledge of the CAGE alcohol screening questions and its impact on practice.

P. Whelton, D. Levine, M. Klag, 1994, Alcohol and alcoholism.

Coffee intake and risk of hypertension: the Johns Hopkins precursors study.

K. Liang, D. Ford, F. Brancati, 2002, Archives of internal medicine.

ORIGINAL INVESTIGATIONS Pathogenesis and Treatment of Kidney Disease and Hypertension Early Detection of Kidney Disease in Community Settings: The Kidney Early Evaluation Program (KEEP)

M. Klag, W. Keane, W. Brown, 2003 .

51 – Epidemiology of Cardiovascular Disease

M. Klag, 2012 .

The US Cancer Moonshot initiative.

Phillip L. Williams, E. Boerwinkle, G. Raskob, 2016, The Lancet. Oncology.

K/DOQI clinical practice guidelines for chronic kidney disease

K. Minaker, T. Ikizler, E. Balk, 2002 .

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Keith C. Norris, A. Gotto, G. Eknoyan, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: a prospective cohort study

N. Powe, M. Klag, N. Levin, 2007, BMC Health Services Research.

Stability of Preferences for End-of-Life Treatment After 3 Years of Follow-up

M. Klag, L. Meoni, Joseph J. Gallo, 2016 .

Frequency of sit-down patient care rounds, attainment of clinical performance targets, hospitalization, and mortality in hemodialysis patients.

N. Powe, A. Levey, M. Klag, 2004, Journal of the American Society of Nephrology : JASN.

Hypertension awareness, treatment, and control in chronic kidney disease.

G. Bakris, A. Collins, Suying Li, 2008, The American journal of medicine.

End-stage renal disease in African-American and white men. 16-year MRFIT findings.

M. Klag, P. K. Whelton, J. D. Neaton, 1997, JAMA.